Kumiko Shimizu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kumiko Shimizu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Akihiko Hirose
6 shared publications- Reiji Kubota
Division of Environmental Chemistry, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan
4 shared publications Maiko Tahara
3 shared publications- Maiko Tahara
Division of Environmental Chemistry, National Institute of Health Sciences
3 shared publications Tetsuji Nishimura
3 shared publications- Tetsuji Nishimura
Graduate School of Environmental Informations, Teikyo Heisei University
3 shared publications
Latest Publications
- 1 October 2011
- Published by Elsevier in Toxicology Letters
- Vol. 206 (2) , 172-177
Time-dependent variation in the biodistribution of C60 in rats determined by liquid chromatography–tandem mass spectrometry
- 1 October 2011
- Published by Elsevier in Toxicology Letters
- Vol. 206 (2) , 172-177
Time-dependent variation in the biodistribution of C60 in rats determined by liquid chromatography–tandem mass spectrometry
- 1 January 2009
- No. 127,p. 65-8
[Development of a liquid chromatography-tandem mass spectrometry method for the determination of fullerenes C60 and C70 in biological samples].
Wide application of fullerenes in various areas would increase the risk of occupational and environmental exposure to human. However, information about toxicity and biological behavior of fullerenes is not sufficient for the risk assessment at present. For the determination of fullerene C60 in biological samples, an analytical method using high performance liquid chromatography--tandem mass spectrometry (LC-MS/MS) and extraction procedure from tissues of experimental animals was established in this study. Using LC-MS/MS with an atmospheric pressure chemical ionization in negative mode, C60 were identified and quantified. After optimization of mobile phase and separation column, good separation of peak of fullerene and sensitivity were obtained in case of using toluene and acetonitrile as the mobile phases and Develosil RPFULLERENE as the separation column. For method validation, rat brain, kidney, liver, lung, spleen tissues and blood were used for recovery tests. Good results were obtained and the recovery percentages were found to be between 98.1% and 106.5%.
- 1 January 2009
- No. 127,p. 65-8
[Development of a liquid chromatography-tandem mass spectrometry method for the determination of fullerenes C60 and C70 in biological samples].
Wide application of fullerenes in various areas would increase the risk of occupational and environmental exposure to human. However, information about toxicity and biological behavior of fullerenes is not sufficient for the risk assessment at present. For the determination of fullerene C60 in biological samples, an analytical method using high performance liquid chromatography--tandem mass spectrometry (LC-MS/MS) and extraction procedure from tissues of experimental animals was established in this study. Using LC-MS/MS with an atmospheric pressure chemical ionization in negative mode, C60 were identified and quantified. After optimization of mobile phase and separation column, good separation of peak of fullerene and sensitivity were obtained in case of using toluene and acetonitrile as the mobile phases and Develosil RPFULLERENE as the separation column. For method validation, rat brain, kidney, liver, lung, spleen tissues and blood were used for recovery tests. Good results were obtained and the recovery percentages were found to be between 98.1% and 106.5%.
- 5 October 2008
- Published by Elsevier in Toxicology Letters
- Vol. 180, S224-S225
Biological effects of fullerene (C60) exposed using liposome in HepG2 cells
- 5 October 2008
- Published by Elsevier in Toxicology Letters
- Vol. 180, S224-S225
Biological effects of fullerene (C60) exposed using liposome in HepG2 cells
- 5 October 2008
- Published by Elsevier in Toxicology Letters
- Vol. 180, S223
Tissue distribution of fullerene C60 in rat after oral and tail-vein administration by LC-MS/MS
- 5 October 2008
- Published by Elsevier in Toxicology Letters
- Vol. 180, S223
Tissue distribution of fullerene C60 in rat after oral and tail-vein administration by LC-MS/MS
- 1 October 2007
- Published by Elsevier in Toxicology Letters
- Vol. 172, S88-S89
Establishment of dispersion methods for in vitro screening system for fullerene
- 1 October 2007
- Published by Elsevier in Toxicology Letters
- Vol. 172, S88-S89
Establishment of dispersion methods for in vitro screening system for fullerene
- 1 September 2006
- Published by Elsevier in Toxicology Letters
- Vol. 164, S214-214
Biological effects of fullerene C60 in mouse embryonic stem cells
- 1 September 2006
- Published by Elsevier in Toxicology Letters
- Vol. 164, S214-214
Biological effects of fullerene C60 in mouse embryonic stem cells
- 2 April 2005
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (9) , 3319-3327
Structure−Activity Relationships of Fluorinated Lysophosphatidic Acid Analogues
Lysophosphatidic acid (LPA, 1- or 2-acyl-sn-glycerol 3-phosphate) displays an intriguing cell biology that is mediated via interactions with seven-transmembrane G-protein-coupled receptors (GPCRs) and the nuclear hormone receptor PPARγ. To identify receptor-selective LPA analogues, we describe a series of fluorinated LPA analogues in which either the sn-1 or sn-2 hydroxyl group was replaced by a fluoro or fluoromethyl substituent. We also describe stabilized phosphonate analogues in which the bridging oxygen of the monophosphate was replaced by an α-monofluoromethylene (−CHF−) or α-difluoromethylene (−CF2−) moiety. The sn-2- and sn-1-fluoro-LPA analogues were unable to undergo acyl migration, effectively “freezing” them in the sn-1-O-acyl or sn-2-O-acyl forms, respectively. We first tested these LPA analogues on insect Sf9 cells induced to express human LPA1, LPA2, and LPA3 receptors. While none of the analogues were found to be more potent than 1-oleoyl-LPA at LPA1 and LPA2, several LPA analogues were potent LPA3-selective agonists. In contrast, 1-oleoyl-LPA had similar activity at all three receptors. The α-fluoromethylene phosphonate analogue 15 activated calcium release in LPA3-transfected insect Sf9 cells at a concentration 100-fold lower than that of 1-oleoyl-LPA. This activation was enantioselective, with the (2S)-enantiomer showing 1000-fold more activity than the (2R)-enantiomer. Similar results were found for calcium release in HT-29 and OVCAR8 cells. Analogue 15 was also more effective than 1-oleoyl-LPA in activating MAPK and AKT in cells expressing high levels of LPA3. The α-fluoromethylene phosphonate moiety greatly increased the half-life of 15 in cell culture. Thus, α-fluoromethylene LPA analogues are unique new phosphatase-resistant ligands that provide enantiospecific and receptor-specific biological readouts.
- 2 April 2005
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (9) , 3319-3327
Structure−Activity Relationships of Fluorinated Lysophosphatidic Acid Analogues
Lysophosphatidic acid (LPA, 1- or 2-acyl-sn-glycerol 3-phosphate) displays an intriguing cell biology that is mediated via interactions with seven-transmembrane G-protein-coupled receptors (GPCRs) and the nuclear hormone receptor PPARγ. To identify receptor-selective LPA analogues, we describe a series of fluorinated LPA analogues in which either the sn-1 or sn-2 hydroxyl group was replaced by a fluoro or fluoromethyl substituent. We also describe stabilized phosphonate analogues in which the bridging oxygen of the monophosphate was replaced by an α-monofluoromethylene (−CHF−) or α-difluoromethylene (−CF2−) moiety. The sn-2- and sn-1-fluoro-LPA analogues were unable to undergo acyl migration, effectively “freezing” them in the sn-1-O-acyl or sn-2-O-acyl forms, respectively. We first tested these LPA analogues on insect Sf9 cells induced to express human LPA1, LPA2, and LPA3 receptors. While none of the analogues were found to be more potent than 1-oleoyl-LPA at LPA1 and LPA2, several LPA analogues were potent LPA3-selective agonists. In contrast, 1-oleoyl-LPA had similar activity at all three receptors. The α-fluoromethylene phosphonate analogue 15 activated calcium release in LPA3-transfected insect Sf9 cells at a concentration 100-fold lower than that of 1-oleoyl-LPA. This activation was enantioselective, with the (2S)-enantiomer showing 1000-fold more activity than the (2R)-enantiomer. Similar results were found for calcium release in HT-29 and OVCAR8 cells. Analogue 15 was also more effective than 1-oleoyl-LPA in activating MAPK and AKT in cells expressing high levels of LPA3. The α-fluoromethylene phosphonate moiety greatly increased the half-life of 15 in cell culture. Thus, α-fluoromethylene LPA analogues are unique new phosphatase-resistant ligands that provide enantiospecific and receptor-specific biological readouts.
- 12 May 2004
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 43 (21) , 2834-2837
Identifying Specific Conformations by Using a Carbohydrate Scaffold: Discovery of Subtype‐Selective LPA‐Receptor Agonists and an Antagonist
- 12 May 2004
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 43 (21) , 2834-2837
Identifying Specific Conformations by Using a Carbohydrate Scaffold: Discovery of Subtype‐Selective LPA‐Receptor Agonists and an Antagonist